Anixa Biosciences Inc — Quarterly Cash Flow (NASDAQ:ANIX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 22.91 M21.59 M18.91 M16.98 M17.65 M16.08 M Total liabilities 2.22 M2.7 M2.19 M2.07 M2.24 M2.13 M Total equity 20.69 M18.89 M16.71 M14.91 M15.41 M13.95 M Total liabilities & shareholders' equities 22.91 M21.59 M18.91 M16.98 M17.65 M16.08 M Total debt —————— Net debt ——————

Haberler

Anixa reports promising survival data in ovarian cancer CAR-T trial

EXCLUSIVE: Anixa Biosciences' Ovarian Cancer Drug Candidate Shows Longer Survival With No Major Safety Issues - Anixa Biosciences (NASDAQ:ANIX)

Anixa Biosciences, meme kanseri aşısı için Meksika’dan patent aldı

Anixa Biosciences receives Mexican patent for breast cancer vaccine

Anixa Biosciences takes over breast cancer vaccine IND from Cleveland Clinic

Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why - Anixa Biosciences (NASDAQ:ANIX)

Anixa’nın meme kanseri aşısı Faz 1 sonuçlarında olumlu sonuçlar gösterdi

Anixa’s breast cancer vaccine shows positive Phase 1 results

Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript

WHO approves name for Anixa’s ovarian cancer CAR-T therapy

Anixa, meme kanseri aşı teknolojisi için ABD patenti alıyor

Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?